Qlife Holding AB Total Assets
Qlife Holding AB total assets. Based on the latest financial reports, Qlife Holding AB (QLIFE) holds total assets worth Skr14.80 Million SEK (≈ $1.59 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see QLIFE company net worth for the company's overall valuation and market capitalisation.
Total Assets of Qlife Holding AB (2019–2025)
Total assets of Qlife Holding AB from 2019 to 2025. This chart illustrates how Qlife Holding AB's total assets have evolved over time, based on quarterly financial data. See today's stock price for Qlife Holding AB for real-time trading data and today's change.
Qlife Holding AB - Asset Composition Analysis
Qlife Holding AB Total Assets Breakdown (December 2025)
Qlife Holding AB total assets breakdown as of December 2025. Qlife Holding AB's total assets of Skr14.80 Million consist of 52.2% current assets and 47.9% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 14.7% |
| Accounts Receivable | Skr202.00K | 2.1% |
| Inventory | Skr3.02 Million | 31.4% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr4.61 Million | 47.9% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2019–2025)
This chart illustrates how Qlife Holding AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Qlife Holding AB working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Qlife Holding AB's current assets represent 52.2% of total assets in 2025, an increase from 10.3% in 2019.
- Cash Position: Cash and equivalents constituted 14.7% of total assets in 2025, up from 5.3% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 47.0% of total assets, a decrease from 87.0% in 2019.
- Asset Diversification: The largest asset category is intangible assets at 47.9% of total assets.
Qlife Holding AB Competitors by Total Assets
Key competitors of Qlife Holding AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥916.43 Million |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Applied BioCode
TW:6598
|
Taiwan | NT$1.03 Billion |
|
Oncosil Medical Ltd
AU:OSL
|
Australia | AU$7.13 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Cleo Diagnostics Ltd
AU:COV
|
Australia | AU$9.96 Million |
|
Radiant Innovation
TWO:3373
|
Taiwan | NT$859.52 Million |
|
MedX Health Corp
V:MDX
|
Canada | CA$1.26 Million |
Qlife Holding AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.31 | 1.89 | 6.45 |
| Quick Ratio | 1.64 | 1.08 | 6.12 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr5.97 Million | Skr2.77 Million | Skr113.39 Million |
Qlife Holding AB - Advanced Valuation Insights
This section examines the relationship between Qlife Holding AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 31.12 |
| Latest Market Cap to Assets Ratio | 0.35 |
| Asset Growth Rate (YoY) | -17.2% |
| Total Assets | Skr9.63 Million |
| Market Capitalization | $3.40 Million USD |
Valuation Analysis
Below Book Valuation: The market values Qlife Holding AB's assets below their book value (0.35x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Qlife Holding AB's assets decreased by 17.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Qlife Holding AB (2019–2025)
The table below shows the annual total assets of Qlife Holding AB from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr9.63 Million ≈ $1.04 Million |
-17.23% |
| 2024-12-31 | Skr11.64 Million ≈ $1.25 Million |
-70.20% |
| 2023-12-31 | Skr39.05 Million ≈ $4.20 Million |
-79.73% |
| 2022-12-31 | Skr192.65 Million ≈ $20.73 Million |
-0.41% |
| 2021-12-31 | Skr193.44 Million ≈ $20.82 Million |
+52.08% |
| 2020-12-31 | Skr127.19 Million ≈ $13.69 Million |
+66.05% |
| 2019-12-31 | Skr76.60 Million ≈ $8.24 Million |
-- |
About Qlife Holding AB
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents in Sweden. The company offers Egoo.Health Platform, a product platform that enables advanced biomarker testing, consisting of a small device, disposable capsules, and the supplementing software. Qlife Holding AB (publ) was incorporated in 2019 and is based in Gothenburg, Sweden.